Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Cardiovascular News

News
Value of Praluent, Repatha Differs by Patient Population
06/23/2016
A systematic review published in JMCP compared the strength of evidence for the PCSK9 inhibitors alirocumab and evolocumab. To learn which patient groups benefit most from each of these cholesterol-lowering drugs, read more.
A systematic review published in JMCP compared the strength of evidence for the PCSK9 inhibitors alirocumab and evolocumab. To learn which patient groups benefit most from each of these cholesterol-lowering drugs, read more.
A systematic review published in...
06/23/2016
First Report Managed Care

Advertisement

News
Add-on Salsalate Does Not Curb Coronary Plaque in the Overweight
06/03/2016
Adding salsalate to statins does not affect levels of noncalcified coronary plaque in overweight and obese patients with stable coronary heart disease.
Adding salsalate to statins does not affect levels of noncalcified coronary plaque in overweight and obese patients with stable coronary heart disease.
Adding salsalate to statins does...
06/03/2016
Pharmacy Learning Network
News
Intensive BP Treatment in Elderly Reduces Cardiovascular Events, Deaths
05/27/2016
In ambulatory adults above age 75, bringing systolic blood pressure to less than 120 mmHg led to significantly lower rates of fatal and nonfatal cardiovascular events and deaths from any cause in the Systolic Blood Pressure Intervention Trial...
In ambulatory adults above age 75, bringing systolic blood pressure to less than 120 mmHg led to significantly lower rates of fatal and nonfatal cardiovascular events and deaths from any cause in the Systolic Blood Pressure Intervention Trial...
In ambulatory adults above age...
05/27/2016
Pharmacy Learning Network
News
Updated Heart Failure Guidelines Endorse Entresto
05/21/2016
New global guidelines on the treatment of heart failure endorse the use of Novartis' Entresto, boosting the prospects for a drug that has struggled to gain traction since its launch last year.
New global guidelines on the treatment of heart failure endorse the use of Novartis' Entresto, boosting the prospects for a drug that has struggled to gain traction since its launch last year.
New global guidelines on the...
05/21/2016
First Report Managed Care

Advertisement

News
Solid Evidence Backs Heart Attack Prevention Initiative
05/16/2016
An overview of systematic reviews shows that high-quality evidence underlies the choice of drugs in the Million Hearts Program for primary prevention of atherosclerotic cardiovascular disease, according to researchers.
An overview of systematic reviews shows that high-quality evidence underlies the choice of drugs in the Million Hearts Program for primary prevention of atherosclerotic cardiovascular disease, according to researchers.
An overview of systematic...
05/16/2016
Pharmacy Learning Network
News
Study: Gout Drug Cardioprotective in Older Adults
05/13/2016
Findings of a new study suggest that the uric acid reducer allopurinol is associated with reduced risk of incident atrial fibrillation (AF) in older adults.
Findings of a new study suggest that the uric acid reducer allopurinol is associated with reduced risk of incident atrial fibrillation (AF) in older adults.
Findings of a new study suggest...
05/13/2016
First Report Managed Care
News
Study: Statins Lower CV Risk in Intermediate-Risk Patients
04/04/2016
In the HOPE-3 trial, researchers investigated the role of cholesterol-lowering therapy alone and with blood pressure-lowering treatment in preventing cardiovascular events in patients considered at intermediate risk for congestive heart...
In the HOPE-3 trial, researchers investigated the role of cholesterol-lowering therapy alone and with blood pressure-lowering treatment in preventing cardiovascular events in patients considered at intermediate risk for congestive heart...
In the HOPE-3 trial, researchers...
04/04/2016
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

What's Trending?

Diagnosing Sarcoidosis: Endosonography versus Bronchoscopy
08/14/2013
The incidence of sarcoidosis, a multisystem granulomatous disease of unclear etiology, is, according to researchers, high, with up to 40 cases per 100,000 individuals. In addition, mortality related to sarcoidosis is increasing. The disease...
The incidence of sarcoidosis, a multisystem granulomatous disease of unclear etiology, is, according to researchers, high, with up to 40 cases per 100,000 individuals. In addition, mortality related to sarcoidosis is increasing. The disease...
The incidence of sarcoidosis, a...
08/14/2013
First Report Managed Care
News
Students Welcomed to Live in Nursing Facilities
02/14/2017
Some nursing homes are allowing college students to move into their facilities under mutually beneficial terms.
Some nursing homes are allowing college students to move into their facilities under mutually beneficial terms.
Some nursing homes are allowing...
02/14/2017
Annals of Long-Term Care
News
FDA Panel Votes Against Approval of GSK Lung Disease Drug
07/25/2018
An expert panel for the FDA did not support the approval of a drug intended for the treatment of COPD.
An expert panel for the FDA did not support the approval of a drug intended for the treatment of COPD.
An expert panel for the FDA did...
07/25/2018
Pharmacy Learning Network
News
Safety and Efficacy of Topical Diclofenac Sodium 1% Gel in Seniors and Younger Patients with Hand Osteoarthritis
03/04/2015
Results, presented at the annual AAPM meeting, revealed that DSG was effective and generally well tolerated for hand OA, regardless of patient age.
Results, presented at the annual AAPM meeting, revealed that DSG was effective and generally well tolerated for hand OA, regardless of patient age.
Results, presented at the annual...
03/04/2015
Annals of Long-Term Care
News
Test Designed to Screen Resistance to Cancer Drug
07/29/2010
07/29/2010
First Report Managed Care

Advertisement

Stay Informed—Sign up today!

Population Health Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use